搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Helicobacter acinonychis 30S ribosomal protein S4 (rpsD) CSB-YP624222HAAF
CSB-EP624222HAAF
CSB-BP624222HAAF
CSB-MP624222HAAF
CSB-EP624222HAAF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Helicobacter acinonychis 50S ribosomal protein L18 (rplR) CSB-YP624223HAAF
CSB-EP624223HAAF
CSB-BP624223HAAF
CSB-MP624223HAAF
CSB-EP624223HAAF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Helicobacter acinonychis 50S ribosomal protein L14 (rplN) CSB-YP624224HAAF
CSB-EP624224HAAF
CSB-BP624224HAAF
CSB-MP624224HAAF
CSB-EP624224HAAF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Helicobacter acinonychis Glycerol-3-phosphate acyltransferase (plsY), partial CSB-YP624225HAAF1
CSB-EP624225HAAF1
CSB-BP624225HAAF1
CSB-MP624225HAAF1
CSB-EP624225HAAF1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Helicobacter acinonychis Pyridoxine 5'-phosphate synthase (pdxJ) CSB-YP624226HAAF
CSB-EP624226HAAF
CSB-BP624226HAAF
CSB-MP624226HAAF
CSB-EP624226HAAF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridioides difficile Proline racemase (CD630_32370) CSB-YP624227CAAQ
CSB-EP624227CAAQ
CSB-BP624227CAAQ
CSB-MP624227CAAQ
CSB-EP624227CAAQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Putative GDP-fucose protein O-fucosyltransferase 1 (C15C7.7) CSB-YP624228CXY
CSB-EP624228CXY
CSB-BP624228CXY
CSB-MP624228CXY
CSB-EP624228CXY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Mitochondrial import receptor subunit TOM40 homolog (C18E9.6) CSB-YP624229CXY
CSB-EP624229CXY
CSB-BP624229CXY
CSB-MP624229CXY
CSB-EP624229CXY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium difficile Probable GTP-binding protein EngB (engB) CSB-YP624230CAAQ
CSB-EP624230CAAQ
CSB-BP624230CAAQ
CSB-MP624230CAAQ
CSB-EP624230CAAQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium difficile Putative sporulation transcription regulator WhiA (whiA) CSB-YP624231CAAQ
CSB-EP624231CAAQ
CSB-BP624231CAAQ
CSB-MP624231CAAQ
CSB-EP624231CAAQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium difficile Porphobilinogen deaminase (hemC) CSB-YP624232CAAQ
CSB-EP624232CAAQ
CSB-BP624232CAAQ
CSB-MP624232CAAQ
CSB-EP624232CAAQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium difficile ATP synthase subunit beta (atpD) CSB-YP624233CAAQ
CSB-EP624233CAAQ
CSB-BP624233CAAQ
CSB-MP624233CAAQ
CSB-EP624233CAAQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium difficile 50S ribosomal protein L31 (rpmE) CSB-YP624234CAAQ
CSB-EP624234CAAQ
CSB-BP624234CAAQ
CSB-MP624234CAAQ
CSB-EP624234CAAQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Putative neuropeptide Y receptor 11 (npr-11), partial CSB-YP624235CXY1
CSB-EP624235CXY1
CSB-BP624235CXY1
CSB-MP624235CXY1
CSB-EP624235CXY1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium difficile Ribosomal RNA small subunit methyltransferase A (rsmA) CSB-YP624236CAAQ
CSB-EP624236CAAQ
CSB-BP624236CAAQ
CSB-MP624236CAAQ
CSB-EP624236CAAQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium difficile 30S ribosomal protein S6 (rpsF) CSB-YP624237CAAQ
CSB-EP624237CAAQ
CSB-BP624237CAAQ
CSB-MP624237CAAQ
CSB-EP624237CAAQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ig-like and fibronectin type-III domain-containing protein C27B7.7 (C27B7.7), partial CSB-YP624238CXY
CSB-EP624238CXY
CSB-BP624238CXY
CSB-MP624238CXY
CSB-EP624238CXY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium difficile Glycine--tRNA ligase beta subunit (glyS), partial CSB-YP624239CAAQ
CSB-EP624239CAAQ
CSB-BP624239CAAQ
CSB-MP624239CAAQ
CSB-EP624239CAAQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium difficile Chaperone protein DnaK (dnaK), partial CSB-YP624240CAAQ
CSB-EP624240CAAQ
CSB-BP624240CAAQ
CSB-MP624240CAAQ
CSB-EP624240CAAQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium difficile 30S ribosomal protein S20 (rpsT) CSB-YP624241CAAQ
CSB-EP624241CAAQ
CSB-BP624241CAAQ
CSB-MP624241CAAQ
CSB-EP624241CAAQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>